Senior Director of Public Affairs - Rare Diseases · Sanofi · company speakers →
Global pharmaceutical, OMP and pediatric EU legislation. Rare diseases policies . Gene Therapy-ATMP . HTA and access frameworks. Cross border access. Patient engagement. Incentives for medicine development. Repurposing. - All aspects of medical affairs across the product life cycle - Compassionate Use and Medical Need programs. Diagnostics. Real world evidence and registries - Multistakeholder engagement I’m a generalist in a highly specialised environment and a Medical Doctor with over 25 years experience primarily in biotechnology and innovative pharmaceutical companies. Strong international experience in medical and policy departments collaborate across functions and across stakeholders.
Is this you? Claim this profile →
No public contact links on file.
Sectors
Sourcing speakers for your event?
Browse the speaker directory →